Cannara Biotech Inc.
TSX:LOVE.TO · Toronto Stock Exchange
+$0.02 today
Vol 0.04M · Avg 0.04M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
12.8%
avg -6.8%
ROIC
10.9%
avg -1.8%
ROA
7.8%
avg -4.8%
Analysis
ROE is currently the strongest return metric at 12.8% versus its period average of -6.8%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Nicholas Sosiak | COO & Interim CFO | $525,000.00 | — | — | — | — |
Zohar Krivorot | Founder, Chief Executive Officer & Chairman | $525,000.00 | — | 49 | — | — |
Avi Krivorot | Chief Technology Officer | $425,000.00 | — | — | — | — |
Etienne Ledoux | Executive Officer | $300,000.00 | — | — | — | — |
Brian Sherman | General Counsel & Vice President Legal Affairs | — | — | — | — | — |
France Landry | Vice President of Human Resources | — | — | — | — | — |
Nick Van Dam | Vice President of Sales | — | — | — | — | — |
Scott Carroll | Vice President of Commercial Strategy & Marketing | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | +46.6% (6yr)1 analysts |
| Revenue | N/A | N/A | +157.6% | +29.3% (6yr)1 analysts |
| Net Income | N/A | N/A | N/A | +47.8% (6yr)1 analysts |
| EBIT | N/A | N/A | N/A | +57.8% (6yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +157.6% over three years. Forward estimates point to EBIT at +57.8% (6yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Auxly Cannabis Group Inc.
TSX:XLY.TO
$257.70M
Quipt Home Medical Corp.
QIPT.TO
$221.44M
Cardiol Therapeutics Inc.
TSX:CRDL.TO
$171.76M
BioSyent Inc.
RX.V
$160.02M
Grown Rogue International Inc.
GRIN.CN
$149.96M
HLS Therapeutics Inc.
TSX:HLS.TO
$133.86M
Jushi Holdings Inc.
JUSH.CN
$133.80M
Satellos Bioscience Inc.
TSX:MSCL.TO
$125.22M
Helix BioPharma Corp.
TSX:HBP.TO
$108.46M
Decibel Cannabis Company Inc.
DB.V
$69.23M
Who manages LOVE.TO?
Cannara Biotech Inc. (LOVE.TO) lists 8 active executives. The top listed executive is Etienne Ledoux, Executive Officer.
Explore More
Continue the stock analysis
Jump to another research area for this company.